Source:http://linkedlifedata.com/resource/pubmed/id/18922905
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
20
|
pubmed:dateCreated |
2008-10-16
|
pubmed:abstractText |
REIC/Dickkopf-3 (Dkk-3), a tumor suppressor gene, has been investigated in gene therapy studies. Our previous study suggested that REIC/Dkk-3-induced apoptosis mainly resulted from phosphorylation of c-Jun-NH(2) kinase (JNK) in prostate cancer cells. However, the precise mechanisms, especially the molecular mechanisms regulating JNK phosphorylation, remain unclear. In this study, we investigated the mechanisms participating in JNK phosphorylation in the context of a refractory cancer disease, malignant mesothelioma (MM). Adenovirus-mediated overexpression of REIC/Dkk-3 induced apoptosis mainly through JNK activation in immortalized MM cells (211H cells). Interestingly, transcriptional down-regulation of inhibition of differentiation-1 (Id-1) was detected in REIC/Dkk-3-overexpressed 211H cells. Moreover, restoration of Id-1 expression antagonized REIC/Dkk-3-induced JNK phosphorylation and apoptosis. Mutagenesis experiments with the 2.1-kb human Id-1 promoter revealed that activating transcription factor 3 (ATF3) and Smad interaction, with their respective binding motifs, was essential for REIC/Dkk-3-mediated suppression of Id-1 promoter activity. ATF3 activation was probably induced by endoplasmic reticulum stress. Finally, we showed strong antitumor effects from REIC/Dkk-3 gene transfer into the pleural cavity in an orthotopic MM mouse model. Relative to control tumor tissue, REIC/Dkk-3-treated tumor tissue showed down-regulated expression of Id-1 mRNA, enhanced expression of phosphorylated JNK, and an increased number of apoptotic cells. In summary, we first showed that both ATF3 and Smad were crucially and synergistically involved in down-regulation of Id-1, which regulated JNK phosphorylation in REIC/Dkk-3-induced apoptosis. Thus, gene therapy with REIC/Dkk-3 may be a promising therapeutic tool for MM.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ATF3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Activating Transcription Factor 3,
http://linkedlifedata.com/resource/pubmed/chemical/Atf3 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/DKK3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Dkk3 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/ID1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Idb1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Inhibitor of Differentiation...,
http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides...,
http://linkedlifedata.com/resource/pubmed/chemical/JNK Mitogen-Activated Protein...,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/Smad Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1538-7445
|
pubmed:author |
pubmed-author:AbarzuaFernandoF,
pubmed-author:HuhNam-HoNH,
pubmed-author:KashiwakuraYujiY,
pubmed-author:KumonHiromiH,
pubmed-author:NasuYasutomoY,
pubmed-author:OchiaiKazuhikoK,
pubmed-author:SakaguchiMasakiyoM,
pubmed-author:TakaokaMunenoriM,
pubmed-author:TanimotoRyutaR,
pubmed-author:WatanabeMasamiM
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8333-41
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18922905-Activating Transcription Factor 3,
pubmed-meshheading:18922905-Animals,
pubmed-meshheading:18922905-Apoptosis,
pubmed-meshheading:18922905-Down-Regulation,
pubmed-meshheading:18922905-Endoplasmic Reticulum,
pubmed-meshheading:18922905-Gene Therapy,
pubmed-meshheading:18922905-HeLa Cells,
pubmed-meshheading:18922905-Humans,
pubmed-meshheading:18922905-Inhibitor of Differentiation Protein 1,
pubmed-meshheading:18922905-Intercellular Signaling Peptides and Proteins,
pubmed-meshheading:18922905-JNK Mitogen-Activated Protein Kinases,
pubmed-meshheading:18922905-Mice,
pubmed-meshheading:18922905-Mice, Inbred BALB C,
pubmed-meshheading:18922905-Multiple Myeloma,
pubmed-meshheading:18922905-NF-kappa B,
pubmed-meshheading:18922905-Phosphorylation,
pubmed-meshheading:18922905-Promoter Regions, Genetic,
pubmed-meshheading:18922905-Smad Proteins
|
pubmed:year |
2008
|
pubmed:articleTitle |
Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis.
|
pubmed:affiliation |
Innovation Center Okayama for Nanobio-Targeted Therapy, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan. yu-kashi@cj9.so-net.ne.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|